A retrospective study to evaluate efficacy and tolerability of bortezomib and dexamethasone salvage therapy in patients with relapsed refractory multiple myeloma.
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2015
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 03 Aug 2015 New trial record
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.